GlassScriptPhysician profile
Peter John Rossi
NPI 1851338545
$145,894.97
in general payments reported to CMS, 2019-2025
32 companies · $92K in 2025
The $92K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $979 · 2020: $12K · 2021: $5,667 · 2022: $16K · 2023: $18K · 2024: $907 · 2025: $92K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $86K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Food and Beverage: $4,700 · Acquisitions: $2,572 · Travel and Lodging: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $86,250.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,387.02 |
| Food and Beverage | $4,700.03 |
| Acquisitions | $2,571.88 |
| Travel and Lodging | $276.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Theragenics Corporation | $80,150.11 | 2019-2025 | |
| Boston Scientific Corporation | $29,825.20 | 2019-2024 | Ams 700, Spaceoar System |
| Sumitomo Pharma America, INC. | $14,613.76 | 2023-2025 | Orgovyx |
| Teleflex LLC | $14,143.40 | 2025 | Barrigel, Urolift |
| Palette Life Sciences, INC. | $3,958.94 | 2022-2023 | |
| Myovant Sciences INC. | $1,306.52 | 2021-2022 | |
| Bioprotect Medical, INC. | $489.93 | 2024-2025 | Bioprotect Balloon Implant System |
| Blue Earth Diagnostics | $278.59 | 2024-2025 | Posluma |
| Bayer Healthcare Pharmaceuticals INC. | $216.00 | 2019-2025 | |
| Arrow International, INC. | $143.65 | 2024 | |
| Angiodynamics, INC. | $105.28 | 2019 | |
| Myriad Genetic Laboratories, INC. | $88.82 | 2023 | Prolaris |
| Isoray, INC | $85.74 | 2022 | |
| Bk Medical Holding Company INC. | $64.00 | 2023 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Elekta, INC. | $59.03 | 2019-2023 | Elekta Medical Linear Accelerator |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $49.73 | 2022-2025 | Truebeam |
| E.R. Squibb & Sons, L.L.C. | $43.47 | 2019 | |
| Novocure INC. | $42.32 | 2021-2022 | |
| Medtronic, INC. | $37.59 | 2025 | Osteocool Rf Ablation System |
| Kyowa Kirin, INC. | $28.95 | 2019 | |
| Lilly USA, LLC | $22.09 | 2019 | |
| Array Biopharma INC | $18.60 | 2019 | |
| Amgen INC. | $15.32 | 2019 | |
| Tactile Systems Technology INC | $15.21 | 2022 | |
| Merck Sharp & Dohme LLC | $15.05 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $13.81 | 2019 | |
| Progenics Pharmaceuticals, INC. | $13.78 | 2023 | Pylarify |
| Takeda Pharmaceuticals U.S.A., INC. | $13.35 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.74 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $12.41 | 2019 | |
| Janssen Biotech, INC. | $11.58 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Rossi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.